Cane Capital Partners, LLC
Position in RNTX — Rein Therapeutics, Inc.
CIK 2086121
ST FRANCISVILLE, LA
Position in RNTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,720
-$4,680 QoQ
Shares Held
18,000
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 59 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cane Capital Partners, LLC holds $18,720 across 1 Biotechnology name. RNTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNTX |
Rein Therapeutics, Inc.
This page
|
18,000 | $18,720 |
All Filings in RNTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,720 | 18,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $23,400 | 18,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $20,880 | 18,000 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||